IP Library Granted Patent US 11,905,343
Granted Patent B2
US 11,905,343 · App. 16/098,584 · Granted Feb 20, 2024

Amylopectin potato starch with improved stability against retrogradation and improved freeze and thaw stability

Inventors: Per Hofvander (Bjärred, SE); Mariette Andersson (Lund, SE); Mathias Samuelsson (Kristianstad, SE); Åke Ståhl (Sösdala, SE)
Assignee: SVERIGES STARKELSEPRODUCENTER, FORENING U.P.A.
C08B30/12C08B30/20C08L3/02C08L3/12C12N15/8213C12N15/8245C12N15/90
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,905,343
App. No.
16/098,584
Granted
Feb 20, 2024
Kind
B2
Abstract

Amylopectin potato starch with improved stability against retrogradation and improved freeze and thaw stability, wherein it contains more than 99% amylopectin, preferably 100% amylopectin, is disclosed, as well as a method for the production of a potato ( Solanum tuberosum ) containing said amylopectin potato starch, wherein said method involves homology-directed mutagenesis using CRISPR/nuclease technology and comprises the following steps: a) provision of potato cells or potato tissue containing potato cells, b) introduction into the nuclei of said potato cells of one or more CRISPR/nuclease complexes each comprising a specific targeting ribonucleotide sequence which is fully or essentially homologous to a target nucleotide sequence located in a DNA sequence immediately upstream of a PAM (5′-NGG-3′protospacer adjacent motif) in a gene coding for a GBSS enzyme and optionally also in a gene coding for an SSII enzyme and/or in a gene coding for an SSIII enzyme, wherein said mutagenesis takes place in one or more alleles of the potato genome, wherein when said targeting ribonucleotide sequence identifies the complementary strand of the target nucleotide sequence, said one or more CRISPR/nuclease complexes cut(s) said DNA sequence, leading to a subsequent complete lack of the ability of the potato to produce a functional GBSSI enzyme, optionally also a functional SSII and/or SSIII enzyme, c) wherein step b) optionally is repeated until the potato lacks the ability to produce said functional GBSSI enzyme, optionally also a functional SSII and/or SSIII enzyme, in all of the alleles, preferably 3 times, a potato obtained by said method, a method for the production of said amylopectin potato starch from said potato, and different uses of said amylopectin potato starch.

Claims (13)

1. Amylopectin potato starch, having more than 99.5% amylopectin, which has been extracted from a potato ( Solanum tuberosum ) in which the expression and/or activity of the GBSSI enzyme, of the SSIII enzyme, and of

the SSII enzyme has been completely eliminated,

wherein, the Amylopectin potato starch has a shorter amylopectin chain length compared to that of native amylopectin potato starch and a degree of branching of more than 5%.

2. The amylopectin potato starch according to claim 1 , having less than 30% syneresis after 2 repeated freeze/thaw cycles according to a standardized freeze/thaw stability test.

3. The amylopectin starch according to claim 1 , which has been purified after extraction from said potato by acid thinning, oxidation, acetylation, hydroxypropylation, cross-linking, sodiumoctenyl succinylation, aluminum-octenyl succinylation, succinylation, pyrodextrinization, enzymatic modifications, alkaline roasting, or cationic modification.

4. The amylopectin potato starch according to claim 1 , which has been gelatinized and further dried to a dry content of more than 80% w/w dry matter (DM).

5. The amylopectin starch according to claim 1 , wherein it has been degraded to a molecular weight of 100 000-1 000 000 Da with enzymatic modification or acid treatment, pyrodextrinization, oxidation degradation, or combinations thereof, or wherein it has been inhibited by alkaline roasting or a bleaching reaction with oxidizing agents.

6. The amylopectin potato starch of claim 1 , consisting essentially of the amylopectin which has been extracted from the potato ( Solanum tuberosum ) in which the expression and/or activity of the GBSSI enzyme, of the SSIII enzyme, and of the SSII enzyme has been completely eliminated, wherein, the Amylopectin potato starch has a shorter amylopectin chain length compared to that of native amylopectin potato starch and a degree of branching of more than 5%.

7. The amylopectin potato starch according to claim 1 , having less than 30% syneresis after 2 repeated freeze/thaw cycles according to a standardized freeze/thaw stability test.

8. The amylopectin potato starch of claim 1 , wherein it has been gelatinized and further dried to a dry content of more than 85% w/w dry matter (DM).

9. The amylopectin potato starch of claim 1 , wherein it has been gelatinized and further dried to a dry content of more than 90% w/w dry matter (DM).

10. The amylopectin starch according to claim 1 , wherein it has been degraded to a molecular weight of 300 000-800 000 Da, with enzymatic modification or acid treatment, pyrodextrinization, oxidation degradation, or combinations thereof, or wherein it has been inhibited by alkaline roasting or a bleaching reaction with oxidizing agents.

11. The amylopectin starch according to claim 1 , wherein it has been degraded to a molecular weight of 500 000-700 000 Da, with enzymatic modification or acid treatment, pyrodextrinization, oxidation degradation, or combinations thereof, or wherein it has been inhibited by alkaline roasting or a bleaching reaction with oxidizing agents.

Assignments (2)
MERGER Recorded Nov 19, 2020
From: LYCKEBY STARCH AB
To: SVERIGES STARKELSEPRODUCENTER, FORENING U.P.A.
Reel/Frame 054414/0349 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 29, 2019
From: HOFVANDER, PER; ANDERSSON, MARIETTE; SAMUELSSON, MATHIAS; STÅHL, ÅKE
To: LYCKEBY STARCH AB
Reel/Frame 048743/0147 →
Priority Claims (1)
SE 1650598-4 · May 3, 2016 · national
Continuity (1)
Related Publication 20190135946A1 · May 9, 2019